Downloads
- March Cytiva Webinar 3/11/2026
-
A Deeper Look At Pharma's Structural Supply Chain Vulnerability
12/31/2025
Fixing limited capacity in pharmaceutical CMC development starts with understanding a complex web of root causes.
-
Survey: SUS Insufficient For 40% Of Biopharma
12/30/2025
New data from BioPlan Associates suggests single-use systems adoption may be plateauing with single-digit growth rates.
-
Allogeneic Cell Therapy's Success Hinges On Perfecting The Platform
12/29/2025
The industry remains far from realizing a manufacturing platform with a repeatable, standardized process that can support broad clinical and commercial deployment.
-
Slurry Handling Solutions
12/23/2025
Streamline your media preparation and column packing. Achieve greater consistency and safety with advanced slurry handling solutions designed for high productivity.
-
Oligosynthesizers For Solid Phase Oligonucleotide Synthesis
12/23/2025
Learn about high-performance and scalable THESYS OS oligosynthesizers, which feature advanced process controls and automation for efficient and reliable oligonucleotide synthesis.
-
847 Continuum Program: Trusted Replacement Parts And Dedicated Service Solutions
12/23/2025
Maximize equipment uptime through a global support network featuring 24/7 technical assistance, genuine replacement parts, and flexible training programs designed to maintain high performance and ensure operational reliability.
-
Synthesis Columns: THESYS® SCS Column And THESYS® ACS Column
12/23/2025
Explore how advanced synthesis columns with specialized flow distribution and ergonomic design optimize reagent dispersal and simplify maintenance to support rigorous cGMP manufacturing requirements.
-
Viral Clearance Testing For Biologics, Vaccines & AAV Therapies
12/23/2025
Viral clearance protects patients by validating virus removal and inactivation in biologics manufacturing, meeting global standards through rigorous, audit-ready studies and expert oversight.
-
The Impact Of PEGs In The Small Molecule API Market
12/22/2025
Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.